1
Future clinical development of anti-angiogenic treatment will benefit from focus on these types of design and style considerations. Up to now, data the utilization of angiogenesis inhibitors brings about meaningful scientific benefit regarding cancer of prostate continues to be elusive, including recent information from CALGB 90401. However, ongoing excitement regarding anti-angiogenesis #links# t